The Federal Reserve is expected to announce its monetary policy decision on Wednesday, and the market is buzzing with anticipation. Investors are hoping for a series of interest-rate cuts from the Fed. However, if the central bank disappoints, many stocks might falter. Bond Yields on a Decline One of the notable indicators is the drop in bond yields. The two-year Treasury yield … [Read more...] about Markets Anticipate Fed Rate Cuts
Corning Projects Positive Outlook for 2024
Corning, the specialty glassmaker, experienced a notable surge in its stock on Tuesday following its optimistic projections for key end markets such as flat-panel displays and optical communications in 2024. Stock SpikeCorning's shares soared by 6% to reach $33.05 during recent trading sessions. This positive response reflects investors' confidence in the company's future … [Read more...] about Corning Projects Positive Outlook for 2024
Impala Platinum Holdings Expects Lower Earnings in H1 2024
Impala Platinum Holdings, a South African platinum miner, has announced that it anticipates a decline in both basic and headline earnings for the first half of fiscal 2024. The company attributes this decline to the weaker valuation of the dollar in relation to the pricing of platinum group metals. For the six months ended December 31, Impala expects headline earnings and … [Read more...] about Impala Platinum Holdings Expects Lower Earnings in H1 2024
Malaysian Shares Rebound After Previous Dip
Malaysian shares managed to turn around their recent decline on Wednesday, with the benchmark FTSE Bursa Malaysia KLCI (FBMKLCI) closing at 1,512.98. Top Performers Tenaga Nasional (5347) emerged as the day's biggest gainer, rising 2.3%. Following closely behind was real estate firm KLCC Property Holdings (5235SS), which saw a 1.7% increase. CELCOMDIGI (6947), a … [Read more...] about Malaysian Shares Rebound After Previous Dip
GSK Raises Long-Term Sales Outlook
GSK, the British pharmaceutical giant, has significantly raised its long-term sales outlook for the period between 2026 and 2031. The company anticipates that the launch of new drugs and vaccines will propel its annual sales to reach £38 billion by the beginning of the next decade. One of the key factors contributing to this positive projection is the hugely successful release … [Read more...] about GSK Raises Long-Term Sales Outlook
